• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低全球变暖潜能值吸入器处方趋势:2018 - 2024年全英国队列比较

Trends in low global warming potential inhaler prescribing: A UK-wide cohort comparison from 2018-2024.

作者信息

Barry Simon M, Davies Gareth R, Forton Julian, Williams Sarah, Thomas Richard, Paxton Paul, Moore Grace, Davies Chris R

机构信息

Respiratory Medicine, Cardiff and Vale UHB, Cardiff, UK.

School of Medicine, Cardiff University, Cardiff, UK.

出版信息

NPJ Prim Care Respir Med. 2025 Feb 20;35(1):9. doi: 10.1038/s41533-025-00415-z.

DOI:10.1038/s41533-025-00415-z
PMID:39979264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11842734/
Abstract

We performed a retrospective cohort analysis comparing trends in low global warming potential (GWP) inhaler prescribing in primary care in England, Scotland, Wales and Northern Ireland between 2018 and 2024 using national prescribing data. There was little change in England, a reduction from 36.6-31.0% in Scotland, a reduction from 36.7-33.2% in Northern Ireland, and an increase from 30.8-41.1% in Wales. Only in Wales was there a simultaneous reduction in high GWP inhalers and an increase in low GWP inhalers. Over the time period of the study there has been a saving of 20,303 tonnes of carbon dioxide equivalent in Wales.

摘要

我们利用国家处方数据进行了一项回顾性队列分析,比较了2018年至2024年期间英格兰、苏格兰、威尔士和北爱尔兰初级保健中低全球变暖潜能值(GWP)吸入器处方的趋势。英格兰变化不大,苏格兰从36.6%降至31.0%,北爱尔兰从36.7%降至33.2%,威尔士从30.8%升至41.1%。只有在威尔士,高GWP吸入器的处方量同时减少,低GWP吸入器的处方量增加。在研究期间,威尔士减少了20303吨二氧化碳当量的排放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2733/11842734/beb9c5b2913b/41533_2025_415_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2733/11842734/b90d71d10d06/41533_2025_415_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2733/11842734/beb9c5b2913b/41533_2025_415_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2733/11842734/b90d71d10d06/41533_2025_415_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2733/11842734/beb9c5b2913b/41533_2025_415_Fig2_HTML.jpg

相似文献

1
Trends in low global warming potential inhaler prescribing: A UK-wide cohort comparison from 2018-2024.低全球变暖潜能值吸入器处方趋势:2018 - 2024年全英国队列比较
NPJ Prim Care Respir Med. 2025 Feb 20;35(1):9. doi: 10.1038/s41533-025-00415-z.
2
Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016.2000年至2016年英国慢性阻塞性肺疾病吸入器处方的变化
Int J Chron Obstruct Pulmon Dis. 2019 Jan 22;14:279-287. doi: 10.2147/COPD.S190086. eCollection 2019.
3
Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017.英国抗糖尿病药物使用情况的变化:2000 - 2017年处方趋势
BMJ Open. 2018 Jul 28;8(7):e022768. doi: 10.1136/bmjopen-2018-022768.
4
A change in the trend in dosulepin usage following the introduction of a prescribing indicator but not after two national safety warnings.在引入一项处方指标后,多塞平的使用趋势发生了变化,但在两项国家层面的安全警告发布后却未出现这种变化。
J Clin Pharm Ther. 2016 Apr;41(2):224-8. doi: 10.1111/jcpt.12376. Epub 2016 Mar 2.
5
Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications.在苏格兰国家医疗服务体系资源有限的情况下,哮喘和慢性阻塞性肺疾病吸入治疗的处方趋势:发现和启示。
Expert Rev Respir Med. 2019 Jul;13(7):679-689. doi: 10.1080/17476348.2019.1624528. Epub 2019 Jun 12.
6
Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries.减少吸入器的碳足迹:在五个欧洲国家分析不同方案的气候和临床影响。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001071.
7
Observational cohort study: deprivation and access to anti-dementia drugs in the UK.观察性队列研究:英国的贫困状况与抗痴呆药物的可及性
Age Ageing. 2016 Jan;45(1):148-54. doi: 10.1093/ageing/afv154. Epub 2015 Nov 18.
8
Trends in gabapentinoid prescribing in patients with osteoarthritis: a United Kingdom national cohort study in primary care.骨关节炎患者中加巴喷丁类药物处方趋势:英国初级保健的全国队列研究。
Osteoarthritis Cartilage. 2019 Oct;27(10):1437-1444. doi: 10.1016/j.joca.2019.06.008. Epub 2019 Jul 2.
9
Changes in trends and pattern of strong opioid prescribing in primary care.基层医疗中强效阿片类药物处方的趋势和模式变化。
Eur J Pain. 2014 Oct;18(9):1343-51. doi: 10.1002/j.1532-2149.2014.496.x. Epub 2014 Apr 22.
10
Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England.切换至低全球变暖潜势吸入器的成本。基于英格兰国民保健服务处方数据的经济和碳足迹分析。
BMJ Open. 2019 Oct 29;9(10):e028763. doi: 10.1136/bmjopen-2018-028763.

引用本文的文献

1
Creating system-wide change in medicine: The role of implementation science in achieving scale and adoption.在医学领域实现全系统变革:实施科学在实现规模效应和推广应用方面的作用。
Future Healthc J. 2025 Jul 23;12(3):100452. doi: 10.1016/j.fhj.2025.100452. eCollection 2025 Sep.

本文引用的文献

1
Comprehensive evidence implies a higher social cost of CO.综合证据表明,CO 的社会成本更高。
Nature. 2022 Oct;610(7933):687-692. doi: 10.1038/s41586-022-05224-9. Epub 2022 Sep 1.
2
Carbon footprint impact of the choice of inhalers for asthma and COPD.哮喘和 COPD 患者吸入器选择的碳足迹影响。
Thorax. 2020 Jan;75(1):82-84. doi: 10.1136/thoraxjnl-2019-213744. Epub 2019 Nov 7.
3
The effect of financial incentives on the quality of health care provided by primary care physicians.经济激励措施对初级保健医生所提供医疗服务质量的影响。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD008451. doi: 10.1002/14651858.CD008451.pub2.
4
Effects of pay for performance on the quality of primary care in England.绩效薪酬对英格兰初级医疗服务质量的影响。
N Engl J Med. 2009 Jul 23;361(4):368-78. doi: 10.1056/NEJMsa0807651.